logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
22/09/2025
After Latam Airlines ordered the E195-E2 aircraft, the stock price of Brazilian aerospace company rose by 3.4%.
Latest
3 m ago
The price of Apple stock rose by 4.1% at one point.
4 m ago
Kitchen consumables (aluminum foil, plastic wrap, garbage bags, etc.) brand manufacturer Reynold Consumer Products (REYN) rose 4% in early trading after being selected to join the S&P SmallCap 600 index. The inclusion, effective on September 24th, reflects Reynold's strong market performance.
4 m ago
Reynolds Consumer Products, a kitchen consumer goods brand manufacturer, saw a 4% increase in early trading, after being added to the S&P SmallCap 600 index. The inclusion will be effective on September 24th, reflecting Reynolds' strong market performance.
6 m ago
Roche pharmaceutical company reported positive results from a late-stage trial of its breast cancer drug combination. The trial met its primary endpoint, showing a significant improvement in progression-free survival, pushing Roche's stock price up by 1.5%.
6 m ago
Roche Pharmaceuticals (RHHBY) reported positive results from a late-stage trial of its breast cancer drug combination, including its new breast cancer drug, giredestrant. The trial met its primary endpoint showing a significant improvement in progression-free survival, leading to a 1.5% increase in Roche's stock price.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.